New Results

In silico investigation of the new UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 variants with a focus at the ACE2-Spike RBD interface

Bruno O. Villoutreix, Vincent Calvez, Anne-Genevieve Marcelin, Abdel-Majid Khatib
doi: https://doi.org/10.1101/2021.01.24.427939

Article usage

Article usage: January 2021 to December 2024

AbstractFullPdf
Jan 2021232221460
Feb 202168864184
Mar 20211734375
Apr 20212363452
May 20211504869
Jun 2021782618
Jul 2021861227
Aug 202142813
Sep 2021691520
Oct 202147510
Nov 20212978
Dec 202161412
Jan 202242310
Feb 20222462
Mar 20222834
Apr 20223176
May 2022251010
Jun 202236969
Jul 202223856
Aug 20221446
Sep 2022221013
Oct 20222475
Nov 20221973
Dec 202216175
Jan 20232011
Feb 202317155
Mar 202312153
Apr 20232173
May 20231443
Jun 20231754
Jul 20231664
Aug 20231476
Sep 20231345
Oct 202324144
Nov 20232083
Dec 20231245
Jan 20242227
Feb 20241724
Mar 20241778
Apr 20241745
May 2024865
Jun 20241464
Jul 202411911
Aug 2024793
Sep 2024261913
Oct 20241343
Nov 20241338
Dec 2024634
Back to top
Posted January 24, 2021.
Download PDF
Email
In silico investigation of the new UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 variants with a focus at the ACE2-Spike RBD interface
Bruno O. Villoutreix, Vincent Calvez, Anne-Genevieve Marcelin, Abdel-Majid Khatib
bioRxiv 2021.01.24.427939; doi: https://doi.org/10.1101/2021.01.24.427939
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area